Plain-language · Issue 3 · 2026-10-28
European Cancer Registry Mapping Reveals Significant Gaps in Real-World Data Readiness
Editorially reviewed research summaries, context, and limitations.
V Zadnik, A Duratović Konjević, M Jurtela, et al.
Summary: A large survey conducted in early 2026, as part of an EU initiative called CancerWatch, mapped 175 population-based cancer registries across 45 European countries. The survey — the most comprehensive of its kind — asked registries about their geographic coverage, how quickly they make data available, their digital infrastructure, and how prepared they are to contribute to the EU's new European Health Data Space (EHDS), a framework designed to make health data more accessible and interoperable across Europe. Key findings: cancer data reaches researchers within two years in only 69% of countries; digital systems vary widely in sophistication; and roughly one in three registries reported little or no awareness of what the EHDS will require of them.
Why it matters: Population-based registries — which aim to record every new cancer diagnosis within a defined geographic area — are a cornerstone of public health surveillance and a growing source of real-world data for research and policy. Knowing where these registries fall short in timeliness, digital capacity, and readiness for new European data standards is a necessary first step toward systematic improvement. For rare cancers and rare diseases generally, where meaningful research requires combining records from many countries, these gaps are particularly consequential: incomplete or poorly connected registries make it harder to assemble the large datasets needed to study conditions that affect relatively few people.
What to keep in mind: The survey's 91% response rate is a genuine strength and lends credibility to the overall picture it paints. However, the findings are based on self-reported answers from registry staff, which means that assessments of digital maturity and EHDS awareness reflect how registries perceive themselves rather than independently verified facts. With a 700-item questionnaire, there is also a real possibility that some respondents interpreted questions differently or experienced fatigue that affected the consistency of their answers. The authors are appropriately cautious in their conclusions and call for coordinated investment rather than overstating what the survey can prove. The directional findings — fragmented data exchange, delays in data availability, uneven readiness for new European standards — are consistent with long-standing observations about European health data infrastructure and are plausible even accounting for the survey's limitations.
Relevance: Patient Registries | Real-World Data | Data Standards | Interoperability | Data Governance
Source: https://pubmed.ncbi.nlm.nih.gov/42830857/
---